Comparison of cutaneous manifestations in systemic polyarteritis nodosa and microscopic polyangiitis

N Kluger1, C Pagnoux, L Guillevin

  • 1Service de Dermatologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Pierre et Marie Curie, Hôpital Tenon, 4 Rue de la Chine, F-75020 Paris, France.

Abstract

Insights

Cutaneous manifestations in microscopic polyangiitis (MPA) and polyarteritis nodosa (PAN) show overlap. Clinical and histological skin findings do not reliably distinguish between MPA and PAN, despite differences in purpura and urticaria prevalence.

Area of Science:

  • Rheumatology
  • Dermatology
  • Pathology

Background:

  • Microscopic polyangiitis (MPA) and polyarteritis nodosa (PAN) are distinct vasculitides.
  • Cutaneous manifestations are common in systemic vasculitides but have not been systematically compared between MPA and PAN since their differentiation.

Purpose of the Study:

  • To compare the clinical and pathological features of skin lesions in patients diagnosed with systemic MPA and PAN.
  • To determine if cutaneous manifestations can aid in differentiating between MPA and PAN.

Main Methods:

  • Retrospective analysis of 162 MPA and 248 PAN patients from the French Vasculitis Study Group database.
  • Clinical data on purpura, livedo, nodules, urticaria, skin necrosis, and ulcers were recorded. Fifty-five skin biopsies were analyzed.
  • Statistical comparison of clinical and histological data between MPA, PAN, and PAN subsets (with/without hepatitis B infection).

Main Results:

  • Cutaneous manifestations were observed in 44% of patients with MPA and PAN.
  • Purpura was the most frequent lesion in MPA (26%) compared to PAN (19%). Urticaria was more frequent in PAN (6%).
  • Skin lesions were more common in PAN patients without hepatitis B infection. Histological data showed no significant differences. Skin lesions correlated with arthralgias and ocular manifestations.

Conclusions:

  • Clinical and histological examination of skin lesions is insufficient to differentiate between microscopic polyangiitis and polyarteritis nodosa.
  • While certain lesions like purpura and urticaria show differential prevalence, they are not definitive diagnostic markers.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...